We are advancing differentiated medicines with the ambition to make treatment less demanding for people living with serious autoimmune diseases.
For people living with serious autoimmune diseases, treatment brings its own demands. Frequent injections, appointments, and the routines of ongoing care can shape how people plan their days and live their lives.
Through oral and longer-acting subcutaneous treatment options, Covant is working to reduce those demands, with the potential for less frequent dosing and greater flexibility in how patients manage their care.
Covant’s ambition
Developing a new generation of FcRn inhibitors means overcoming some of the fundamental challenges of peptide medicines. Covant is addressing those challenges through two complementary areas of innovation.
Through targeted molecular modifications, we are engineering peptides that resist breakdown in the body, improve exposure following oral dosing, and remain active in circulation longer. These advances support the pursuit of oral treatment and less frequent injections.
Getting a peptide medicine into the bloodstream requires more than designing the molecule itself. We are developing formulations that bring drug candidates and absorption-supporting ingredients together at the gut wall, helping address a key barrier to oral delivery.
We're advancing a differentiated pipeline of FcRn inhibitors, including oral and long-acting injectable therapies.
Our leadership brings together scientific expertise, a shared sense of ownership, and the determination to challenge assumptions, follow the evidence, and advance better medicines.
Covant is entering a defining new chapter, moving from drug discovery to clinical development with the ambition to lead in FcRn medicines.
We're building a team that shares our determination to advance better treatment options for people living with serious autoimmune diseases.
Ingenuity starts with asking thoughtful questions and being willing to see things differently. We welcome fresh perspectives, give good ideas room to develop, and put them to work with purpose and scientific rigor.
Drug development takes tenacity. Progress requires patience and determination, especially when challenges arise. We're committed to doing the work it takes to move promising science forward.
At Covant, individual contributions have a visible impact. We expect people to take initiative, influence decisions, and shape the company’s future. The buck stops with us.